Article
Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
Frontiers in immunology - 1 Jan 2020
Yanagimachi Masakatsu, Kato Koji, Iguchi Akihiro, Sasaki Koji, Kiyotani Chikako, Koh Katsuyoshi, Koike Takashi, Sano Hideki, Shigemura Tomonari, Muramatsu Hideki, Okada Keiko, Inoue Masami, Tabuchi Ken, Nishimura Toyoki, Mizukami Tomoyuki, Nunoi Hiroyuki, Imai Kohsuke, Kobayashi Masao, Morio Tomohiro
Abstract excerpt
Hematopoietic cell transplantation (HCT) is established as a curative treatment for severe chronic granulomatous disease (CGD). However, outcomes of HCT for CGD in Japan had not been precisely reported. We evaluated the outcome of HCT for CGD in Japan by means of a nationwide survey. A total of 91 patients (86 males and 5 females) with CGD who received HCT between 1992 and 2013 was investigated. Their median age...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
